Table 3.
Genes differentially expressed in common among colon cancer cell lines resistant to MTX
| GenBank ID | Gene name | Description | Ratio HT29 | Ratio Caco-2 |
|---|---|---|---|---|
| AI144299 | DHFR | Dihydrofolate reductase | 7.25 | 46.35 |
| BC005238 | FXYD3 | FXYD domain containing ion transport regulator 3 | 7.24 | 2.20 |
| BC003584 | DHFR | Dihydrofolate reductase | 6.96 | 50.23 |
| BC000192 | DHFR | Dihydrofolate reductase | 6.89 | 38.31 |
| NM_002380 | MATN2 | Matrilin 2 | 6.62 | 4.70 |
| BU078629 | ZFYVE16 | Zinc finger, FYVE domain containing 16 | 6.06 | 22.73 |
| NM_001975 | ENO2 | Enolase 2 (gamma, neuronal) | 5.98 | 2.04 |
| NM_017954 | CADPS2 | Ca2+-dependent activator protein for secretion 2 | 5.60 | 2.27 |
| AI991103 | AXIIR | Similar to annexin II receptor | 5.14 | 2.03 |
| NM_000791 | DHFR | Dihydrofolate reductase | 4.71 | 21.17 |
| U05598 | AKR1C2 | Aldo-keto reductase family 1, member C2 | 4.63 | 10.15 |
| M33376 | AKR1C2 | Aldo-keto reductase family 1, member C2 | 4.41 | 8.89 |
| NM_012242 | DKK1 | Dickkopf homolog 1 | 4.25 | 2.56 |
| NM_014867 | KBTBD11 | Kelch repeat and BTB (POZ) domain containing 11 | 4.22 | 2.14 |
| AB037848 | KIAA1427 | Synaptotagmin XIII | 4.13 | 9.56 |
| NM_014733 | ZFYVE16 | Zinc finger, FYVE domain containing 16 | 4.11 | 15.6 |
| NM_001353 | AKR1C1 | Aldo-keto reductase family 1, member C1 | 3.94 | 8.87 |
| NM_002439 | MSH3 | MutS homolog 3 | 3.87 | 4.00 |
| S68290 | AKR1C1 | Aldo-keto reductase family 1, member C1 | 3.66 | 9.45 |
| J04810 | MSH3 | MutS homolog 3 | 3.27 | 8.23 |
| NM_000691 | ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | 2.86 | 3.81 |
| AI718385 | SLC26A2 | Solute carrier family 26 member 2 | 2.76 | 2.02 |
| NM_003069 | SMARCA1 | SWI/SNF related, regulator of chromatin a1 | 2.60 | 2.49 |
| AB029026 | TACC1 | Transforming, acidic coiled-coil containing protein 1 | 2.35 | 3.89 |
| NM_006283 | TACC1 | Transforming, acidic coiled-coil containing protein 1 | 2.31 | 3.26 |
| AF188298 | DAB2 | Disabled homolog 2 | 2.29 | 2.11 |
| NM_020299 | AKR1B10 | Aldo-keto reductase family 1, member B10 | 2.26 | 22.95 |
| BC006471 | MLLT11 | Myeloid/lymphoid or mixed-lineage leukemia | 2.18 | 2.60 |
| W93554 | SH3PXD2A | SH3 and PX domains 2A | 2.14 | 3.45 |
| NM_014778 | NUPL1 | Nucleoporin like 1 | 0.46 | 0.43 |
| NM_006033 | LIPG | Lipase, endothelial | 0.40 | 0.42 |
| NM_012338 | TM4SF12 | Transmembrane 4 superfamily member 12 | 0.39 | 0.38 |
| NM_007150 | ZNF185 | Zinc finger protein 185 (LIM domain) | 0.38 | 0.42 |
| AB014605 | MAGI2 | Membrane associated guanylate kinase | 0.38 | 0.30 |
| AB033831 | SCDGF | Platelet derived growth factor C | 0.35 | 0.35 |
| NM_021021 | SNTB1 | Syntrophin, beta 1 | 0.35 | 0.23 |
| NM_021822 | APOBEC3G | Apolipoprotein B, catalytic polypeptide-like 3G | 0.30 | 0.08 |
| AB039791 | ARP11 | Actin-related protein Arp11 | 0.29 | 0.46 |
| NM_013352 | SART2 | Squamous cell carcinoma antigen | 0.22 | 0.31 |
| NM_004362 | CLGN | Calmegin | 0.21 | 0.19 |
| AI912583 | GLIPR1 | GLI pathogenesis-related 1 (glioma) | 0.21 | 0.45 |
| Z19574 | KRT17 | Keratin 17 | 0.19 | 0.46 |
| NM_003186 | TAGLN1 | Transgelin | 0.19 | 0.14 |
| NM_014059 | RGC32 | Response gene to complement 32 | 0.17 | 0.44 |
| BE872674 | CLEC3A | C-type lectin domain family 3, member A | 0.15 | 0.24 |
| NM_003212 | TDGF1/3 | Teratocarcinoma-derived growth factor 1/3 | 0.13 | 0.47 |
| BC000069 | RARRES2 | Retinoic acid receptor responder 2 | 0.07 | 0.33 |
| AF110400 | FGF19 | Fibroblast growth factor 19 | 0.06 | 0.26 |
| NM_006851 | GLIPR1 | GLI pathogenesis-related 1 | 0.05 | 0.28 |
| NM_006169 | NNMT | Nicotinamide N-methyltransferase | 0.04 | 0.24 |
| AF208043 | IFI16 | Interferon, gamma-inducible protein 16 | 0.03 | 0.38 |
| BG256677 | IFI16 | Interferon, gamma-inducible protein 16 | 0.02 | 0.40 |
| NM_006169 | NNMT | Nicotinamide N-methyltransferase | 0.02 | 0.24 |
Genes differentially expressed by at least twofold with a P-value < 0.05 including multiple testing correction were compared between HT29 and Caco-2 cells using Venn diagrams in GeneSpring GX software v 7.3.1. The table includes the GenBank IDs for all genes, their respective common names and the associated description. The ratio column corresponds to the fold change in expression of each gene relative to its sensitive counterpart.